This Week at FDA: Shuren pushes for LDT reform, GAO to investigate device recalls, and more
This Week at FDAMichael Mezher • Joanne S. Eglovitch
Biologics/ biosimilars/ vaccinesDiagnostics/IVDsMedical DevicesPharmaceuticalsProduct LifecycleRegulatory Intelligence/PolicyUnited States